Statement on missing ICIJ journalist Micah Reddy 
TRANSCRIPT: ‘China Retains Levers for Long-Term Territorial Ambitions’ 
On Indonesia’s new oligarchy, China’s state bank, and other stories | Asia Sentinel Stories of the Week 
A surgical procedure for Alzheimer’s disease being tested in Hong Kong has the potential to improve patients’ ability to take care of their basic needs such as getting dressed and remaining socially engaged.
The clinical application was pioneered by a mainland Chinese doctor in Hangzhou as early as 2018 and quickly gained nationwide popularity, fuelled by viral social media videos showing dramatic post-surgery transformation of patients.
However, uncertainty about the procedure’s safety and effectiveness led China’s National Health Commission to ban its unregulated use in July 2025, pledging to review it when sufficient evidence was available.
CUHK researchers obtained approval last year and have recruited four patients so far for clinical trials, with one recovering so well that he seemed like a “completely new person … so sharp”, according to his wife.
Dr Tor Chiu, an honorary associate professor of surgery at CUHK, said his research team hoped to verify whether the procedure, performed under strict scientific controls, could improve the condition of Alzheimer’s patients.
He added that the research team was currently recruiting potential patients.
Don't Miss:
-
Middle powers don’t have to wait for a Trump-Xi-Putin summit
-
Woman dies after suspected dog attack in Hong Kong’s Yuen Long
-
Murder trial of slain Hong Kong socialite Abby Choi’s former relatives to begin
-
University calls for government funds for shared sites in Northern Metropolis
-
‘Staunch patriot, close friend’: Beijing official hails Tung Chee-hwa’s legacy